One novel FTO inhibitor, FB23-2, was designed to bind with FTO and showed a significant suppressive effect on the proliferation and enhancement of human AML cell line apoptosis in vitro (Huang et al., 2019). This evidence concerns the gene FTO and acute myeloid leukemia.